您好!博飞美科试剂欢迎您! 400-608-7598

琥珀酰辅酶A 钠盐,85%

Succinyl Coenzyme A Sodium
博飞美科提供的所有产品仅用于科研等非医疗用途,非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料,可至下方“质量控制”中下载
PN04488
PERFEMIKER
108347-97-3
C25H40N7O19P3S.XNa
865.59
品牌 货号 包装 纯度 目录价 会员价 库存 数量 购买车
PERFEMIKER PN04488-5mg 5mg 85% ¥3276.55 登录可见优惠价格
产品名称: 琥珀酰辅酶A 钠盐,85%
中文别名: 琥珀酰辅酶A钠盐;琥珀酰辅酶A;琥珀酰辅酶A 钠盐
英文名称: Succinyl Coenzyme A Sodium
英文别名: Coenzyme A, S-(hydrogenbutanedioate), sodium salt (9CI);Succinyl coenzyme A sodium salt;disodium 1-{(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-[(hydroxyphosphinato)oxy]tetrahydrofuran-2-yl}-3,5,9-trihydroxy-8,8-dimethyl-10,14,19-trioxo-2,4,6-trioxa-18-thia-11,15-diaza-3,5-diphosphadocosan-22-oate 3,5-dioxide (non-preferred name);Succinyl CoA, Li-salt;succinyl coenzyme A sodium;coenzyme A succinyl derivative, trisodium salt;108347-97-3;108347-97-3;1-{(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-4-hydroxy-3-[(hydroxyphosphinato)oxy]oxolan-2-yl}-3,5,9-trihydroxy-8,8-dimethyl-3,5,10,14,19-pentaoxo-2,4,6-trioxa-18-thia-11,15-diaza-3lambda~5~,5lambda~5~-diphosphadocosan-22-oate (non-preferred name);1-{(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-4-hydroxy-3-[(hydroxyphosphinato)oxy]oxolan-2-yl}-3,5,9-trihydroxy-8,8-dimethyl-3,5,10,14,19-pentaoxo-2,4,6-trioxa-18-thia-11,15-diaza-3lambda~5~,5lambda~5~-diphosphadocosan-22-oate (non-preferred name);4-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-[hydroxy(oxido)phosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-4-oxobutanoate;4-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-[hydroxy(oxido)phosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-4-oxobutanoate;DTXSID90849581;DTXSID90849581;SUCCINYL COENZYME A SODIUM SALT;SUCCINYL COENZYME A SODIUM SALT;Succinyl Coenzyme A Sodium
品牌: PERFEMIKER
CAS号: 108347-97-3
分子式: C25H40N7O19P3S.XNA
分子量: 865.59
纯度: 85%
详细描述:

琥珀酰辅酶A 钠盐,85%

暂无相关参考文献
搜索质检报告(COA)